|
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
<b>Results</b>: We found that the lncRNA HCP5 is induced by TGFβ and transcriptionally regulated by SMAD3<i>,</i> which promotes LUAD tumor growth and metastasis.
|
31131047 |
2019 |
|
Stevens-Johnson Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique.
|
24322967 |
2014 |
|
Toxic Epidermal Necrolysis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique.
|
24322967 |
2014 |
|
Graves Disease
|
0.120 |
Biomarker
|
disease |
BEFREE |
HCP5 and MAGI3 SNPs were further correlated with age of GD onset.
|
25345847 |
2015 |
|
Malignant tumor of colon
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
HCP5 expression in CC tissues and cell lines was detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR).
|
31002129 |
2019 |
|
Colon Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
HCP5 expression in CC tissues and cell lines was detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR).
|
31002129 |
2019 |
|
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
HLA complex P5 (HCP5), a long non-coding RNA (lncRNA), has been shown to be implicated in several types of cancer, such as follicular thyroid carcinoma (PTC), the main type of thyroid cancer.
|
31102936 |
2019 |
|
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
HLA complex P5 (HCP5), a long non-coding RNA (lncRNA), has been shown to be implicated in several types of cancer, such as follicular thyroid carcinoma (PTC), the main type of thyroid cancer.
|
31102936 |
2019 |
|
Follicular thyroid carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
HLA complex P5 (HCP5), a long non-coding RNA (lncRNA), has been shown to be implicated in several types of cancer, such as follicular thyroid carcinoma (PTC), the main type of thyroid cancer.
|
31102936 |
2019 |
|
Papillary thyroid carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
HLA complex P5 (HCP5), a long non-coding RNA (lncRNA), has been shown to be implicated in several types of cancer, such as follicular thyroid carcinoma (PTC), the main type of thyroid cancer.
|
31102936 |
2019 |
|
Malignant neoplasm of thyroid
|
0.010 |
Biomarker
|
disease |
BEFREE |
HLA complex P5 (HCP5), a long non-coding RNA (lncRNA), has been shown to be implicated in several types of cancer, such as follicular thyroid carcinoma (PTC), the main type of thyroid cancer.
|
31102936 |
2019 |
|
Thyroid Neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
HLA complex P5 (HCP5), a long non-coding RNA (lncRNA), has been shown to be implicated in several types of cancer, such as follicular thyroid carcinoma (PTC), the main type of thyroid cancer.
|
31102936 |
2019 |
|
Thyroid carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
HLA complex P5 (HCP5), a long non-coding RNA (lncRNA), has been shown to be implicated in several types of cancer, such as follicular thyroid carcinoma (PTC), the main type of thyroid cancer.
|
31102936 |
2019 |
|
Triple Negative Breast Neoplasms
|
0.020 |
Biomarker
|
disease |
BEFREE |
HCP5 knockdown induced TNBC cell apoptosis, and inhibited cell proliferation and orthotopic xenograft tumor growth.
|
31215169 |
2019 |
|
Triple-Negative Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
HCP5 knockdown induced TNBC cell apoptosis, and inhibited cell proliferation and orthotopic xenograft tumor growth.
|
31215169 |
2019 |
|
Malignant Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
HCP5 overexpression decreased SKCM cell malignancy in vitro by upregulating <i>RARRES3</i>, possibly via sponging miR-1286.
|
31496735 |
2019 |
|
Primary malignant neoplasm
|
0.020 |
AlteredExpression
|
group |
BEFREE |
HCP5 overexpression decreased SKCM cell malignancy in vitro by upregulating <i>RARRES3</i>, possibly via sponging miR-1286.
|
31496735 |
2019 |
|
Carpal Tunnel Syndrome
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
A genome-wide association analysis identifies 16 novel susceptibility loci for carpal tunnel syndrome.
|
30833571 |
2019 |
|
Mucocutaneous Lymph Node Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.
|
28855716 |
2017 |
|
Diabetes Mellitus, Insulin-Dependent
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.
|
17632545 |
2007 |
|
HIV Infections
|
0.040 |
GeneticVariation
|
group |
BEFREE |
A genome-wide association study of people with incident human immunodeficiency virus (HIV) infection selected from nine different cohorts identified allelic polymorphisms, which associated with either viral set point (HCP5 and 5' HLA-C) or with HIV disease progression (RNF39 and ZNRD1).
|
19693088 |
2009 |
|
Psoriasis
|
0.130 |
GeneticVariation
|
disease |
GWASDB |
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci.
|
18369459 |
2008 |
|
Psoriasis
|
0.130 |
GeneticVariation
|
disease |
GWASCAT |
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci.
|
18369459 |
2008 |
|
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
After screening and analysis, we identified four important prognosis-related lncRNAs (HOTAIR, SNHG16, HCP5, and TINCR), and constructed a prognostic model, one (HCP5) of which has not previously been identified in the context of breast cancer.
|
30618123 |
2019 |
|
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
After screening and analysis, we identified four important prognosis-related lncRNAs (HOTAIR, SNHG16, HCP5, and TINCR), and constructed a prognostic model, one (HCP5) of which has not previously been identified in the context of breast cancer.
|
30618123 |
2019 |